Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation
- PMID: 15564480
- PMCID: PMC533897
- DOI: 10.1128/JVI.78.24.13708-13716.2004
Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation
Abstract
Proteolytic processing of the dengue virus polyprotein is mediated by host cell proteases and the virus-encoded NS2B-NS3 two-component protease. The NS3 protease represents an attractive target for the development of antiviral inhibitors. The three-dimensional structure of the NS3 protease domain has been determined, but the structural determinants necessary for activation of the enzyme by the NS2B cofactor have been characterized only to a limited extent. To test a possible functional role of the recently proposed Phix(3)Phi motif in NS3 protease activation, we targeted six residues within the NS2B cofactor by site-specific mutagenesis. Residues Trp62, Ser71, Leu75, Ile77, Thr78, and Ile79 in NS2B were replaced with alanine, and in addition, an L75A/I79A double mutant was generated. The effects of these mutations on the activity of the NS2B(H)-NS3pro protease were analyzed in vitro by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of autoproteolytic cleavage at the NS2B/NS3 site and by assay of the enzyme with the fluorogenic peptide substrate GRR-AMC. Compared to the wild type, the L75A, I77A, and I79A mutants demonstrated inefficient autoproteolysis, whereas in the W62A and the L75A/I79A mutants self-cleavage appeared to be almost completely abolished. With exception of the S71A mutant, which had a k(cat)/K(m) value for the GRR-AMC peptide similar to that of the wild type, all other mutants exhibited drastically reduced k(cat) values. These results indicate a pivotal function of conserved residues Trp62, Leu75, and Ile79 in the NS2B cofactor in the structural activation of the dengue virus NS3 serine protease.
Figures





Similar articles
-
Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.Biochem J. 2006 Jul 1;397(1):203-11. doi: 10.1042/BJ20051767. Biochem J. 2006. PMID: 16489931 Free PMC article.
-
The active essential CFNS3d protein complex.FEBS J. 2006 Aug;273(16):3650-62. doi: 10.1111/j.1742-4658.2006.05369.x. FEBS J. 2006. PMID: 16911516
-
Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain.Virology. 1993 Apr;193(2):888-99. doi: 10.1006/viro.1993.1198. Virology. 1993. PMID: 8460492
-
Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.Antiviral Res. 2008 Nov;80(2):94-101. doi: 10.1016/j.antiviral.2008.07.001. Epub 2008 Jul 30. Antiviral Res. 2008. PMID: 18674567 Review.
-
The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development.Antiviral Res. 2015 Jun;118:148-58. doi: 10.1016/j.antiviral.2015.03.014. Epub 2015 Apr 2. Antiviral Res. 2015. PMID: 25842996 Review.
Cited by
-
Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.Biochem J. 2007 Feb 1;401(3):743-52. doi: 10.1042/BJ20061136. Biochem J. 2007. PMID: 17067286 Free PMC article.
-
Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response.Clin Exp Immunol. 2016 Jan;183(1):114-28. doi: 10.1111/cei.12701. Epub 2015 Oct 18. Clin Exp Immunol. 2016. PMID: 26340409 Free PMC article.
-
Isolation and characterization of selective and potent human Fab inhibitors directed to the active-site region of the two-component NS2B-NS3 proteinase of West Nile virus.Biochem J. 2010 Apr 14;427(3):369-76. doi: 10.1042/BJ20100074. Biochem J. 2010. PMID: 20156198 Free PMC article.
-
1H, 13C and 15N resonance assignment of backbone and IVL-methyl side chain of the S135A mutant NS3pro/NS2B protein of Dengue II virus reveals unique secondary structure features in solution.Biomol NMR Assign. 2022 Apr;16(1):135-145. doi: 10.1007/s12104-022-10071-w. Epub 2022 Feb 12. Biomol NMR Assign. 2022. PMID: 35149939 Free PMC article.
-
Development and utility of an in vitro, fluorescence-based assay for the discovery of novel compounds against dengue 2 viral protease.Trop Med Health. 2016 Aug 10;44:22. doi: 10.1186/s41182-016-0025-6. eCollection 2016. Trop Med Health. 2016. PMID: 27551237 Free PMC article.
References
-
- Arias, C. F., F. Preugschat, and J. H. Strauss. 1993. Dengue virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology 193:888-899. - PubMed
-
- Barbato, G., D. O. Cicero, M. C. Nardi, C. Steinkuehler, R. Cortese, R. De Francesco, and R. Bazzo. 1999. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism. J. Mol. Biol. 289:371-384. - PubMed
-
- Bianchi, E., S. Orru, F. Dal Piaz, R. Ingenito, A. Casbarra, G. Biasiol, U. Koch, P. Pucci, and A. Pessi. 1999. Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors. Biochemistry 38:13844-13852. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous